| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAN
|
aggrecan
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACTR8
|
ARP8 actin-related protein 8 homolog (yeast)
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHCY
|
adenosylhomocysteinase
|
|
ALB
|
albumin
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase
|
|
AMH
|
anti-Mullerian hormone
|
|
AMN
|
amnion associated transmembrane protein
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANO5
|
anoctamin 5
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APITD1
|
apoptosis-inducing, TAF9-like domain 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AR
|
androgen receptor
|
|
ARG1
|
arginase 1
|
|
ATAD2
|
ATPase family, AAA domain containing 2
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
AURKA
|
aurora kinase A
|
|
AVP
|
arginine vasopressin
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGN
|
biglycan
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD7
|
bromodomain containing 7
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C2
|
complement component 2
|
|
C3
|
complement component 3
|
|
C5AR1
|
complement component 5a receptor 1
|
|
C8ORF4
|
chromosome 8 open reading frame 4
|
|
CA2
|
carbonic anhydrase II
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CALR
|
calreticulin
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAPN10
|
calpain 10
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CAPZA1
|
capping protein (actin filament) muscle Z-line, alpha 1
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCNA1
|
cyclin A1
|
|
CCNB2
|
cyclin B2
|
|
CCND1
|
cyclin D1
|
|
CCNG1
|
cyclin G1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD1D
|
CD1d molecule
|
|
CD247
|
CD247 molecule
|
|
CD28
|
CD28 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD70
|
CD70 molecule
|
|
CD80
|
CD80 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CENPA
|
centromere protein A
|
|
CENPB
|
centromere protein B, 80kDa
|
|
CENPE
|
centromere protein E, 312kDa
|
|
CFB
|
complement factor B
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CISD1
|
CDGSH iron sulfur domain 1
|
|
CLU
|
clusterin
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL5A1
|
collagen, type V, alpha 1
|
|
COL5A2
|
collagen, type V, alpha 2
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
COQ2
|
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CRB1
|
crumbs family member 1, photoreceptor morphogenesis associated
|
|
CREB3L1
|
cAMP responsive element binding protein 3-like 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYBB2
|
crystallin, beta B2
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CST3
|
cystatin C
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DBF4
|
DBF4 zinc finger
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNM2
|
dynamin 2
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPP8
|
dipeptidyl-peptidase 8
|
|
DPP9
|
dipeptidyl-peptidase 9
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4EBP2
|
eukaryotic translation initiation factor 4E binding protein 2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELN
|
elastin
|
|
ENG
|
endoglin
|
|
ENHO
|
energy homeostasis associated
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
EPHA5
|
EPH receptor A5
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP1
|
fatty acid binding protein 1, liver
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FANCM
|
Fanconi anemia, complementation group M
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FBP1
|
fructose-1,6-bisphosphatase 1
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FHIT
|
fragile histidine triad
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
FOXL2
|
forkhead box L2
|
|
FOXO3
|
forkhead box O3
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FST
|
follistatin
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FTL
|
ferritin, light polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAA
|
glucosidase, alpha; acid
|
|
GABRA3
|
gamma-aminobutyric acid (GABA) A receptor, alpha 3
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GABRR1
|
gamma-aminobutyric acid (GABA) A receptor, rho 1
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALM
|
galactose mutarotase (aldose 1-epimerase)
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GATA3
|
GATA binding protein 3
|
|
GBA
|
glucosidase, beta, acid
|
|
GCG
|
glucagon
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GEM
|
GTP binding protein overexpressed in skeletal muscle
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GGCX
|
gamma-glutamyl carboxylase
|
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
|
GH2
|
growth hormone 2
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA8
|
gap junction protein, alpha 8, 50kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIK1
|
glutamate receptor, ionotropic, kainate 1
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSTCD
|
glutathione S-transferase, C-terminal domain containing
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GUK1
|
guanylate kinase 1
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBB
|
hemoglobin, beta
|
|
HDAC2
|
histone deacetylase 2
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPF
|
heterogeneous nuclear ribonucleoprotein F
|
|
HOXB13
|
homeobox B13
|
|
HOXB5
|
homeobox B5
|
|
HPCA
|
hippocalcin
|
|
HPX
|
hemopexin
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPE1
|
heat shock 10kDa protein 1
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR5A
|
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled
|
|
HTT
|
huntingtin
|
|
IAPP
|
islet amyloid polypeptide
|
|
IBSP
|
integrin-binding sialoprotein
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGES
|
immunoglobulin E concentration, serum
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGKC
|
immunoglobulin kappa constant
|
|
IGKV@
|
immunoglobulin kappa variable cluster
|
|
IGLV@
|
immunoglobulin lambda variable cluster
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL27
|
interleukin 27
|
|
IL27RA
|
interleukin 27 receptor, alpha
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
INHA
|
inhibin, alpha
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IP6K2
|
inositol hexakisphosphate kinase 2
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB6
|
integrin, beta 6
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCTD18
|
potassium channel tetramerization domain containing 18
|
|
KDR
|
kinase insert domain receptor
|
|
KIF5B
|
kinesin family member 5B
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KL
|
klotho
|
|
KLF8
|
Kruppel-like factor 8
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT18
|
keratin 18, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT6A
|
keratin 6A, type II
|
|
KRT8
|
keratin 8, type II
|
|
LAMA5
|
laminin, alpha 5
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LDOC1
|
leucine zipper, down-regulated in cancer 1
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEO1
|
Leo1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LHX4
|
LIM homeobox 4
|
|
LIN9
|
lin-9 DREAM MuvB core complex component
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPL
|
lipoprotein lipase
|
|
LRPAP1
|
low density lipoprotein receptor-related protein associated protein 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LTF
|
lactotransferrin
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
|
MAOA
|
monoamine oxidase A
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGAT5B
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B
|
|
MGP
|
matrix Gla protein
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR130A
|
microRNA 130a
|
|
MIR148B
|
microRNA 148b
|
|
MIR15B
|
microRNA 15b
|
|
MIR23B
|
microRNA 23b
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MLLT11
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MMRN1
|
multimerin 1
|
|
MPZ
|
myelin protein zero
|
|
MSH3
|
mutS homolog 3
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MSX1
|
msh homeobox 1
|
|
MTDH
|
metadherin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
NDEL1
|
nudE neurodevelopment protein 1-like 1
|
|
NDRG4
|
NDRG family member 4
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NEIL2
|
nei endonuclease VIII-like 2 (E. coli)
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFYA
|
nuclear transcription factor Y, alpha
|
|
NGB
|
neuroglobin
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1
|
|
NMNAT3
|
nicotinamide nucleotide adenylyltransferase 3
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRP1
|
neuropilin 1
|
|
OBSCN
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
|
|
OCA2
|
oculocutaneous albinism II
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OR10G4
|
olfactory receptor, family 10, subfamily G, member 4
|
|
OTOF
|
otoferlin
|
|
OXTR
|
oxytocin receptor
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAFAH1B1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PDCD2
|
programmed cell death 2
|
|
PDCD2L
|
programmed cell death 2-like
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PER3
|
period circadian clock 3
|
|
PF4
|
platelet factor 4
|
|
PFKM
|
phosphofructokinase, muscle
|
|
PGAM5
|
phosphoglycerate mutase family member 5
|
|
PGR
|
progesterone receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCZ1
|
phospholipase C, zeta 1
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLK1
|
polo-like kinase 1
|
|
PLK2
|
polo-like kinase 2
|
|
PMEL
|
premelanosome protein
|
|
PMP22
|
peripheral myelin protein 22
|
|
PNLIPRP3
|
pancreatic lipase-related protein 3
|
|
PON1
|
paraoxonase 1
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
PPP1CB
|
protein phosphatase 1, catalytic subunit, beta isozyme
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKCB
|
protein kinase C, beta
|
|
PRNP
|
prion protein
|
|
PROM1
|
prominin 1
|
|
PRTN3
|
proteinase 3
|
|
PSEN1
|
presenilin 1
|
|
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3
|
|
PSMD4
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTN
|
pleiotrophin
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPRB
|
protein tyrosine phosphatase, receptor type, B
|
|
PXN
|
paxillin
|
|
PYY
|
peptide YY
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD23A
|
RAD23 homolog A (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG1
|
recombination activating gene 1
|
|
RAG2
|
recombination activating gene 2
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RBL1
|
retinoblastoma-like 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
RGS1
|
regulator of G-protein signaling 1
|
|
RGS17
|
regulator of G-protein signaling 17
|
|
RGS7
|
regulator of G-protein signaling 7
|
|
RGS9
|
regulator of G-protein signaling 9
|
|
RHOC
|
ras homolog family member C
|
|
RIC3
|
RIC3 acetylcholine receptor chaperone
|
|
RLS4
|
Restless legs syndrome 4
|
|
RMI1
|
RecQ mediated genome instability 1
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RRAD
|
Ras-related associated with diabetes
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
S100B
|
S100 calcium binding protein B
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
SAFB
|
scaffold attachment factor B
|
|
SATB2
|
SATB homeobox 2
|
|
SCG2
|
secretogranin II
|
|
SCLY
|
selenocysteine lyase
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SDHAF1
|
succinate dehydrogenase complex assembly factor 1
|
|
SDHAF2
|
succinate dehydrogenase complex assembly factor 2
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SELL
|
selectin L
|
|
SELPLG
|
selectin P ligand
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SETX
|
senataxin
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SGSH
|
N-sulfoglucosamine sulfohydrolase
|
|
SH3BP2
|
SH3-domain binding protein 2
|
|
SIRT1
|
sirtuin 1
|
|
SIX1
|
SIX homeobox 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC45A2
|
solute carrier family 45, member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLC9A4
|
solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4
|
|
SMARCAL1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPACA3
|
sperm acrosome associated 3
|
|
SPANXA1
|
sperm protein associated with the nucleus, X-linked, family member A1
|
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPTB
|
spectrin, beta, erythrocytic
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRGAP2
|
SLIT-ROBO Rho GTPase activating protein 2
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAU1
|
staufen double-stranded RNA binding protein 1
|
|
STRA13
|
stimulated by retinoic acid 13
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
TAPBP
|
TAP binding protein (tapasin)
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TAZ
|
tafazzin
|
|
TBX21
|
T-box 21
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFRC
|
transferrin receptor
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
THBS1
|
thrombospondin 1
|
|
THOP1
|
thimet oligopeptidase 1
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TK2
|
thymidine kinase 2, mitochondrial
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TMPO
|
thymopoietin
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOMM70A
|
translocase of outer mitochondrial membrane 70 homolog A (S. cerevisiae)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOP3A
|
topoisomerase (DNA) III alpha
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TRD
|
T cell receptor delta locus
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRG
|
T cell receptor gamma locus
|
|
TRIM25
|
tripartite motif containing 25
|
|
TRIM5
|
tripartite motif containing 5
|
|
TSHB
|
thyroid stimulating hormone, beta
|
|
TTK
|
TTK protein kinase
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
|
VAMP3
|
vesicle-associated membrane protein 3
|
|
VCP
|
valosin containing protein
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VPS13B
|
vacuolar protein sorting 13 homolog B (yeast)
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WFIKKN2
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WT1
|
Wilms tumor 1
|
|
XBP1
|
X-box binding protein 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XIST
|
X inactive specific transcript (non-protein coding)
|
|
XYLT1
|
xylosyltransferase I
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZNF224
|
zinc finger protein 224
|
|
ZNF350
|
zinc finger protein 350
|
